80_FR_32683 80 FR 32573 - National Institute on Drug Abuse; Notice of Webinar Meeting

80 FR 32573 - National Institute on Drug Abuse; Notice of Webinar Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 110 (June 9, 2015)

Page Range32573-32573
FR Document2015-14062

Pursuant to the NIH Reform Act of 2006 (42 U.S.C. Sec.281 (d)(4)), notice is hereby given that the National Institute on Drug Abuse (NIDA) will provide two opportunities to enable public discussion on the Institute's proposal to reorganize its extramural program.

Federal Register, Volume 80 Issue 110 (Tuesday, June 9, 2015) 
[Federal Register Volume 80, Number 110 (Tuesday, June 9, 2015)]
[Notices]
[Page 32573]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-14062]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Webinar Meeting

SUMMARY: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. Sec.281 
(d)(4)), notice is hereby given that the National Institute on Drug 
Abuse (NIDA) will provide two opportunities to enable public discussion 
on the Institute's proposal to reorganize its extramural program.

DATES: Opportunity # 1: Beginning June 12, 2015, the NIDA Director will 
make available an online summary of the proposed reorganization at: 
http://www.drugabuse.gov/about-nida/noras-blog. Comments will be 
invited.
    Opportunity # 2: A public webinar will take place on June 19, 2015 
at 3 p.m. Eastern Time, with attendance limited to space available.

ADDRESSES: Webex Meeting via: https://nih.webex.com/nih/j.php?MTID=mcc2b711f67cee4a9abe2b2a9c1d78a0d. Participants are 
encouraged to join this meeting at the link provided at least 20 
minutes prior to the scheduled start time.
    Instructions for joining the event can be found below:
    1. Enter the Web URL above into your web browser address bar and 
hit enter.
    2. If requested, enter your name and email address. 3. If a 
password is required, enter the meeting password: Success1
    4. Click ``Join.''
    For audio support to this event, the audio conference information 
is as follows:
    Phone Number: 1-877-668-4493 Call-in toll-free number (US/Canada).
    Participant Code No. 620 763 396.
    Any interested person may file written comments by sending an email 
to [email protected] by June 24, 2015. The statement should 
include the individual's name, contact information and, when 
applicable, professional affiliation.

FOR FURTHER INFORMATION CONTACT:  Dave Daubert, Deputy Executive 
Officer, National Institute on Drug Abuse, Office of Management, 6001 
Executive Boulevard, NSC Building, Room 5274,Bethesda, MD 20892, 301-
402-1652, [email protected].

SUPPLEMENTARY INFORMATION: The agenda for the web meeting will consist 
of updates made to the proposed reorganization plans for the NIDA 
extramural program based on findings by the National Advisory Council 
on Drug Abuse. The proposal seeks to bridge and integrate the key areas 
of translational neuroscience and neurobehavioral research, as well as 
capitalize on emerging scientific opportunities, while reducing 
barriers to scientific and interdisciplinary collaboration.
    Members of the public wishing to attend the Webinar must view the 
discussion via webex link https://nih.webex.com/nih/j.php?MTID=mcc2b711f67cee4a9abe2b2a9c1d78a0d and enter the audio 
conference information above from their telephone. Upon opening the 
link provided, please contact your IT support group for assistance in 
uploading any necessary drivers (e.g. MBR2 player) prior to the start 
of this event.

    Dated: June 3, 2015.
Nora Volkow,
Director, National Institute on Drug Abuse, National Institutes of 
Health.
[FR Doc. 2015-14062 Filed 6-8-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 110 / Tuesday, June 9, 2015 / Notices 32573 TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Average Number of Number of burden per Total burden Form name responses per respondents response hours respondent (in hours) Provider Survey ............................................................................................... 300 1 15/60 75 Patient Qualitative Interview ............................................................................ 20 1 1 20 Provider Qualitative Interview .......................................................................... 20 1 1 20 Total .......................................................................................................... ........................ ........................ ........................ 105 Darius Taylor, to NIDAOrgComments@mail.nih.gov by amended (5 U.S.C. App.), notice is Information Collection Clearance Officer. June 24, 2015. The statement should hereby given of the following meetings. [FR Doc. 2015–14000 Filed 6–8–15; 8:45 am] include the individual’s name, contact The meetings will be closed to the BILLING CODE 4150–28–P information and, when applicable, public in accordance with the professional affiliation. provisions set forth in sections FOR FURTHER INFORMATION CONTACT: 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND Dave Daubert, Deputy Executive Officer, as amended. The grant applications and HUMAN SERVICES National Institute on Drug Abuse, Office the discussions could disclose of Management, 6001 Executive confidential trade secrets or commercial National Institutes of Health Boulevard, NSC Building, Room property such as patentable material, 5274,Bethesda, MD 20892, 301–402– and personal information concerning National Institute on Drug Abuse; 1652, daubert@nih.gov. Notice of Webinar Meeting individuals associated with the grant SUPPLEMENTARY INFORMATION: The applications, the disclosure of which SUMMARY: Pursuant to the NIH Reform agenda for the web meeting will consist would constitute a clearly unwarranted Act of 2006 (42 U.S.C. Sec.281 (d)(4)), of updates made to the proposed invasion of personal privacy. notice is hereby given that the National reorganization plans for the NIDA Name of Committee: National Human Institute on Drug Abuse (NIDA) will extramural program based on findings Genome Research Institute Special Emphasis provide two opportunities to enable by the National Advisory Council on Panel; Genome Sequencing Program public discussion on the Institute’s Drug Abuse. The proposal seeks to Coordinating Center (GSPCC). proposal to reorganize its extramural bridge and integrate the key areas of Date: June 23, 2015. program. translational neuroscience and Time: 11:00 a.m. to 2:00 p.m. neurobehavioral research, as well as Agenda: To review and evaluate grant DATES: Opportunity # 1: Beginning June capitalize on emerging scientific applications. 12, 2015, the NIDA Director will make opportunities, while reducing barriers to Place: National Human Genome Research available an online summary of the scientific and interdisciplinary Institute 3rd Floor Conference Room, 5635 proposed reorganization at: http:// collaboration. Fishers Lane Rockville, MD, (Telephone www.drugabuse.gov/about-nida/noras- Members of the public wishing to Conference Call). blog. Comments will be invited. attend the Webinar must view the Contact Person: Lita Proctor, Ph.D., Opportunity # 2: A public webinar discussion via webex link https:// Extramural Research Programs Staff, Program will take place on June 19, 2015 at 3 nih.webex.com/nih/j.php?MTID Director, Human Microbiome Project, p.m. Eastern Time, with attendance =mcc2b711f67cee4a9abe2b2a9c1d7 National Human Genome Research Institute limited to space available. 8a0d and enter the audio conference 5635 Fishers Lane, Suite 4076, Bethesda, MD ADDRESSES: Webex Meeting via: 20892, 301 496–4550, information above from their telephone. https://nih.webex.com/nih/j.php?MTID= Upon opening the link provided, please proctorlm@mail.nih.gov. mcc2b711f67cee4a9abe2b2a9c1d78a0d. contact your IT support group for This notice is being published less than 15 Participants are encouraged to join this assistance in uploading any necessary days prior to the meeting due to the timing meeting at the link provided at least 20 limitations imposed by the review and drivers (e.g. MBR2 player) prior to the minutes prior to the scheduled start funding cycle. start of this event. time. Name of Committee: National Human Dated: June 3, 2015. Genome Research Institute Special Emphasis Instructions for joining the event can be found below: Nora Volkow, Panel; Sequencing Center RFAs. 1. Enter the Web URL above into your Director, National Institute on Drug Abuse, Date: July 20–21, 2015. web browser address bar and hit enter. National Institutes of Health. Time: 8:00 a.m. to 5:00 p.m. 2. If requested, enter your name and [FR Doc. 2015–14062 Filed 6–8–15; 8:45 am] Agenda: To review and evaluate grant applications. email address. 3. If a password is BILLING CODE 4140–01–P Place: Renaissance Arlington Capital View required, enter the meeting password: Hotel, Studio B, 2800 South Potomac Success1 Avenue, Arlington, VA 22202. 4. Click ‘‘Join.’’ DEPARTMENT OF HEALTH AND Contact Person: Rudy O. Pozzatti, Ph.D., For audio support to this event, the HUMAN SERVICES Scientific Review Officer Scientific Review tkelley on DSK3SPTVN1PROD with NOTICES audio conference information is as Branch, National Human Genome Research follows: National Institutes of Health Institute 5635 Fishers Lane, Suite 4076, MSC Phone Number: 1–877–668–4493 Call- National Human Genome Research 9306, Rockville, MD 20852, (301) 402–0838, in toll-free number (US/Canada). Institute; Notice of Closed Meetings pozzattr@mail.nih.gov. Participant Code No. 620 763 396. (Catalogue of Federal Domestic Assistance Any interested person may file Pursuant to section 10(d) of the Program Nos. 93.172, Human Genome written comments by sending an email Federal Advisory Committee Act, as Research, National Institutes of Health, HHS) VerDate Sep<11>2014 18:47 Jun 08, 2015 Jkt 235001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\09JNN1.SGM 09JNN1


Document Created: 2015-12-15 15:26:06
Document Modified: 2015-12-15 15:26:06
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOpportunity # 1: Beginning June 12, 2015, the NIDA Director will make available an online summary of the proposed reorganization at: http://www.drugabuse.gov/about-nida/noras-blog. Comments will be invited.
ContactDave Daubert, Deputy Executive Officer, National Institute on Drug Abuse, Office of Management, 6001 Executive Boulevard, NSC Building, Room 5274,Bethesda, MD 20892, 301- 402-1652, [email protected]
FR Citation80 FR 32573 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR